Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 2.27x is 40% above its 5-year average of 1.62x, near the high end of its 5-year range (-7.17x–3.20x).
53.21% above its 12-month average of 1.48x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 0.19x.
INTEREST COVERAGE RATIO
2.27x
INTEREST COVERAGE RATIO AVG TTM
1.48x
INTEREST COVERAGE RATIO AVG 3Y
1.92x
INTEREST COVERAGE RATIO AVG 5Y
1.62x
INTEREST COVERAGE RATIO AVG 10Y
1.18x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+53.21%
CURRENT VS 3Y AVG
+18.40%
CURRENT VS 5Y AVG
+40.04%
CURRENT VS 10Y AVG
+91.59%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.12x
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
+144.38%
vs the sector median at left
Collegium Pharmaceutical, Inc.
Market Cap
$704.46M
Interest Coverage Ratio
2.27x
TTM Avg
1.48x
3Y Avg
1.92x
5Y Avg
1.62x
Market Cap
$717.21M
Interest Coverage Ratio
-67.01x
TTM Avg
15.61x
3Y Avg
8.76x
5Y Avg
6.40x
Market Cap
$690.35M
Interest Coverage Ratio
-1286.22x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$723.04M
Interest Coverage Ratio
N/A
TTM Avg
578.36x
3Y Avg
578.36x
5Y Avg
578.36x
Market Cap
$722.55M
Interest Coverage Ratio
-85.20x
TTM Avg
23.14x
3Y Avg
23.14x
5Y Avg
23.14x
Market Cap
$690.61M
Interest Coverage Ratio
-696.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$743.33M
Interest Coverage Ratio
-22.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$749.48M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$750.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Collegium Pharmaceutical, Inc. (COLL) | $704.46M | 2.27x | 1.48x | 1.92x | 1.62x |
| Achieve Life Sciences, Inc. (ACHV)vs › | $717.21M | -67.01x | 15.61x | 8.76x | 6.40x |
| Anteris Technologies Global Corp. (AVR)vs › | $690.35M | -1286.22x | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $723.04M | N/A | 578.36x | 578.36x | 578.36x |
| Cytek Biosciences, Inc. (CTKB)vs › | $722.55M | -85.20x | 23.14x | 23.14x | 23.14x |
| Faeth Therapeutics, Inc. (FTH)vs › | $690.61M | -696.50x | N/A | N/A | N/A |
| Candel Therapeutics, Inc. (CADL)vs › | $743.33M | -22.78x | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $749.48M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $750.01M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $662.64M | 35.83x | 47.17x | 33.36x | 33.36x |
Interest Coverage
2.3x
Debt/Equity
2.75
Current Ratio
1.03
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 0.19x |
| 2026-03-31 | 2.02x |
| 2025-12-31 | 0.57x |
| 2025-09-30 | 2.92x |
| 2025-06-30 | 1.72x |
| 2025-03-31 | 1.04x |
| 2024-12-31 | 1.68x |
| 2024-09-30 | 1.89x |
| 2024-06-30 | 3.05x |
| 2024-03-31 | 2.85x |
| 2023-12-31 | 3.20x |
| 2023-09-30 | 2.17x |
| 2023-06-30 | 1.63x |
| 2023-03-31 | 1.15x |
| 2022-12-31 | 0.57x |
| 2022-09-30 | 1.07x |
| 2022-06-30 | 0.63x |
| 2022-03-31 | -1.72x |
| 2021-12-31 | -7.17x |
| 2021-09-30 | 2.77x |
| 2021-06-30 | 3.03x |
| 2021-03-31 | 3.70x |
| 2020-12-31 | 1.94x |
| 2020-09-30 | 2.43x |
| 2020-06-30 | 2.00x |
| 2020-03-31 | 1.05x |
| 2019-12-31 | -11.25x |
| 2019-09-30 | -27.96x |
| 2019-06-30 | -21.22x |
| 2019-03-31 | -42.70x |
| 2018-12-31 | 4.58x |
| 2018-09-30 | -1.91x |
| 2018-06-30 | -1.18x |
| 2018-03-31 | -2.32x |
| 2017-12-31 | -97.68x |
| 2016-09-30 | -13221.00x |
| 2016-06-30 | -532.04x |
| 2016-03-31 | -236.17x |
| 2015-12-31 | -106.02x |
| 2015-09-30 | -95.52x |
| 2015-06-30 | -46.21x |
| 2015-03-31 | -23.42x |
| 2014-12-31 | -23.43x |
| 2014-09-30 | -127.55x |
| 2014-06-30 | -140.97x |
| 2014-03-31 | -129.10x |
